Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2550 of 3284 entries
View as:

Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00090675 Org: User:
Start: 01/31/06 End: 11/30/07 Due: 11/30/08

A Study to Determine the Effect of Food on the Pharmacokinetics of Oral AZD8931 Tablets

Phase: N/A Priority: Normal
NCT ID: NCT00879346 Org: User:
Start: 03/31/09 End: 07/31/09 Due: 07/31/10

Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events

Phase: N/A Priority: Normal
NCT ID: NCT01730534 Org: User:
Start: 04/25/13 End: 09/11/18 Due: 09/11/19

Effectiveness of Statins on Lipid Goal Attainment and Lipid Parameters in PCI Patients

Phase: N/A Priority: Normal
NCT ID: NCT02561845 Org: User:
Start: 10/31/15 End: 10/31/15 Due: 10/31/16

Quetiapine Extended Release Depression Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT00640562 Org: User:
Start: 02/29/08 End: 02/28/10 Due: 02/28/11

An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.

Phase: N/A Priority: Normal
NCT ID: NCT03084471 Org: User:
Start: 06/05/17 End: 12/16/22 Due: 12/16/23

Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07)

Phase: N/A Priority: Normal
NCT ID: NCT00246922 Org: User:
Start: 12/31/04 End: 10/31/07 Due: 10/31/08

Gefitinib Long-term Survivor Study

Phase: N/A Priority: Normal
NCT ID: NCT02932345 Org: User:
Start: 10/31/16 End: 07/04/17 Due: 07/04/18

A Study to Prevent Rebleeding After Initial Successful Primary Endoscopic Haemostasis of a Bleeding Peptic Ulcer

Phase: N/A Priority: Normal
NCT ID: NCT00251979 Org: User:
Start: 10/31/05 End: 12/31/07 Due: 12/31/08

AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00463814 Org: User:
Start: 03/08/07 End: 12/31/25 Due: 12/31/26

A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg

Phase: N/A Priority: Normal
NCT ID: NCT00313170 Org: User:
Start: 05/30/06 End: 03/13/19 Due: 03/13/20

Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01928771 Org: User:
Start: 09/19/13 End: 04/05/16 Due: 04/05/17

To Assess the Safety, Tolerability, and Pharmacokinetics of AZD7624 in Healthy Volunteers and COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT01817855 Org: User:
Start: 09/30/13 End: 10/31/14 Due: 10/31/15

FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis

Phase: N/A Priority: Normal
NCT ID: NCT00486798 Org: User:
Start: 05/31/07 End: 08/31/07 Due: 08/31/08

Acid Suppressing Drug Seizure Epidemiology Study

Phase: N/A Priority: Normal
NCT ID: NCT01744301 Org: User:
Start: 03/31/13 End: 12/31/14 Due: 12/31/15

Evaluation of the Effect of Pramlintide on Satiety and Food Intake

Phase: N/A Priority: Normal
NCT ID: NCT00042601 Org: User:
Start: 07/31/02 End: 10/31/03 Due: 10/31/04

Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in Korea

Phase: N/A Priority: Normal
NCT ID: NCT01372956 Org: User:
Start: 08/31/11 End: 10/31/11 Due: 10/31/12

Adherence to Gastro-protection in Non-steroidal Anti-inflammatory Drug (NSAID) Using Patients

Phase: N/A Priority: Normal
NCT ID: NCT00699725 Org: User:
Start: 05/31/08 End: 01/31/09 Due: 01/31/10

Reversal of Ventricular Remodeling With Toprol-XL

Phase: N/A Priority: Normal
NCT ID: NCT00038077 Org: User:
Start: 08/31/01 End: 09/30/03 Due: 09/30/04

A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00402077 Org: User:
Start: 11/30/06 End: 08/31/07 Due: 08/31/08

"Me and My Heart" Study

Phase: N/A Priority: Normal
NCT ID: NCT02615704 Org: User:
Start: 02/11/16 End: 03/07/19 Due: 03/07/20

Description of the Clinical Outcomes of Hospitalized Patients With Heart Failure With Different Serum Potassium Levels

Phase: N/A Priority: Normal
NCT ID: NCT05184998 Org: User:
Start: 11/30/21 End: 07/13/22 Due: 07/13/23

Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (6 to 11 y) (BY9010/M1-206)

Phase: N/A Priority: Normal
NCT ID: NCT00163462 Org: User:
Start: 10/31/04 End: 11/30/05 Due: 11/30/06

Open-label Extension Study of Brazikumab in Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT04277546 Org: User:
Start: 03/03/20 End: 10/10/23 Due: 10/10/24

Symbicort in Chronic Obstruktive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT00612976 Org: User:
Start: 02/28/06 End: - Due: -